Literature DB >> 23587710

Exposure assessment of lovastatin in Pu-erh tea.

Zhen-Jun Zhao1, You-Zhao Pan, Qin-Jin Liu, Xing-Hui Li.   

Abstract

This paper reports the results of an extensive survey on the levels of lovastatin in Pu-erh tea samples. The microbial source of lovastatin was assessed by testing the ability of fungi with higher isolation frequency in the Pu-erh tea samples to produce lovastatin on Czapek yeast extract agar (CYA). Lovastatin was not detected in any of the raw Pu-erh tea samples without storage but was found in almost all the ripe Pu-erh tea samples, with lovastatin contents ranging from 20.61 ng/gdw to 226.38 ng/gdw. After five years' storage, the lovastatin levels increased obviously in ripe Pu-erh tea samples and 55% of raw Pu-erh tea samples from 2007 were found to contain lovastatin with concentrations ranging between 28.41 ng/gdw and 228.61 ng/gdw. With increasing storage time, lovastatin concentration in ripe Pu-erh tea, and the occurrence and concentration of lovastatin for raw Pu-erh tea increased significantly. Three genera of fungi: Aspergillus, Penicillium and Trichoderma were often isolated from Pu-erh tea samples. A total of 40 strains from 3 fungal genera were selected to test their ability to produce lovastatin. Only 6 strains, Aspergillus tubingensis, Aspergillus wentii, Aspergillus fumigatus, Penicillium chrysogenum, Trichoderma asperellum and Trichoderma citrinoviride, were able to produce lovastatin reaching concentrations of 9.59 ± 0.42 ng/g CYA, 2.33 ± 0.21 ng/g CYA, 2.77 ± 0.13 ng/g CYA, 3.36 ± 0.69 ng/g CYA, 4.8 ± 0.17 ng/g CYA, and 1.47 ± 0.36 ng/g CYA respectively in Czapek yeast extract agar.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587710     DOI: 10.1016/j.ijfoodmicro.2013.03.018

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  7 in total

Review 1.  Anti-obesogenic and antidiabetic effects of plants and mushrooms.

Authors:  Jan Martel; David M Ojcius; Chih-Jung Chang; Chuan-Sheng Lin; Chia-Chen Lu; Yun-Fei Ko; Shun-Fu Tseng; Hsin-Chih Lai; John D Young
Journal:  Nat Rev Endocrinol       Date:  2016-09-16       Impact factor: 43.330

Review 2.  Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

Authors:  Albert Selva-O'Callaghan; Marcelo Alvarado-Cardenas; Iago Pinal-Fernández; Ernesto Trallero-Araguás; José Cesar Milisenda; María Ángeles Martínez; Ana Marín; Moisés Labrador-Horrillo; Cándido Juárez; Josep María Grau-Junyent
Journal:  Expert Rev Clin Immunol       Date:  2018-02-23       Impact factor: 4.473

3.  Sentinel trees as a tool to forecast invasions of alien plant pathogens.

Authors:  AnnaMaria Vettraino; Alain Roques; Annie Yart; Jian-ting Fan; Jiang-hua Sun; Andrea Vannini
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

Review 4.  Selectins-The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules-A Review.

Authors:  Igor Tvaroška; Chandrabose Selvaraj; Jaroslav Koča
Journal:  Molecules       Date:  2020-06-19       Impact factor: 4.411

5.  Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.

Authors:  Gitte S Jensen; Joni L Beaman; Yi He; Zhixin Guo; Henry Sun
Journal:  Clin Interv Aging       Date:  2016-03-24       Impact factor: 4.458

6.  Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway.

Authors:  Steven M Muskal; Joe Sliman; John Kokai-Kun; Mark Pimentel; Vince Wacher; Klaus Gottlieb
Journal:  F1000Res       Date:  2016-04-08

Review 7.  Mycotoxins in Tea: Occurrence, Methods of Determination and Risk Evaluation.

Authors:  Irina Sedova; Mariya Kiseleva; Victor Tutelyan
Journal:  Toxins (Basel)       Date:  2018-10-30       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.